175
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia

, , &
Pages 473-481 | Published online: 23 Oct 2014

References

  • DrummondMFSculpherMJTorranceGWO’BrienBJStoddartGLMethods for the Economic Evaluation of Health Care Programmes3rd edNew York, NYOxford University Press2005
  • RobinsonRCost-utility analysisBMJ199330769088598628401133
  • ShiroiwaTSungYKFukudaTLangHCBaeSCTsutaniKInternational survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?Health Econ201019442243719382128
  • ApplebyJDevlinNParkinDNICE’s cost effectiveness thresholdBMJ2007335761635835917717337
  • BarniehLMannsBHarrisAA synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countriesValue Health20141719810824438723
  • LimTOLimYNWongHSCost effectiveness evaluation of the Ministry of Health Malaysia dialysis programmeMed J Malaysia199954444245211072461
  • GohKLCutlerAChuaABOptimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patientsJ Gastroenterol Hepatol1999141323810029275
  • LooCYKandiahMArumugamGCost efficiency and cost effectiveness of cataract surgery at the Malaysian Ministry of Health ophthalmic servicesInt Ophthalmol2004252818715290886
  • PriceNDaveyPBirinyi-StrachanLThe cost-effectiveness of olanzapine for the treatment of schizophrenia in MalaysiaMalaysian Journal of Psychiatry20051315362
  • HooiLSLimTOGohAEconomic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, MalaysiaNephrology (Carlton)2005101253215705178
  • CheahIGSoosaiAPWongSLLimTOCost-Effectiveness NICU Study Group. Cost-effectiveness analysis of Malaysian neonatal intensive care unitsJ Perinatol2005251475315372062
  • HassaliMAAMohamed IbrahimMISyed SulaimanSAA clinical and economic study of community-acquired pneumonia between single versus combination therapyPharm World Sci200527324925316096896
  • RizalAMEnnaMHAljunidSMRohanaAGSoehardyZNorellaCTKCost-effectiveness analysis of continuous venovenous hemofiltration therapy in the treatment of sepsis in Hospital Universiti Kebangsaan Malaysia: a comparison between high volume and standard dose hemofiltrationMalaysian Journal of Community Health200612118
  • IbrahimMIAbdullahMNaingLAbdullahJMIdrisZAljunidSMCost effectiveness analysis of using multiple neuromodalities in treating severe traumatic brain injury in a developing country like MalaysiaAsian J Surg200730426126617962129
  • AnnemansLDemarteauNHuSAn Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathyValue Health200811335436417888064
  • AlefanQIbrahimMIMRazakTAAyubACost-effectiveness of antihypertensive treatment in MalaysiaMalaysian Journal of Pharmaceutical Sciences200972137152
  • EzatSWAljunidSComparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in MalaysiaAsian Pac J Cancer Prev201011494395121133606
  • AljunidSAbuduxikeGAhmedZSulongSNurAMGohAImpact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in MalaysiaBMC Infect Dis20111124821936928
  • DranitsarisGTruterILubbeMSSriramanakoppaNNMendoncaVMMahagaonkarSBUsing pharmacoeconomic modelling to determine value-based pricing for new pharmaceuticals in MalaysiaMalays J Med Sci2011184324322589671
  • WHO Commission on Macroeconomics and HealthMacroeconomics and Health: Investing in Health for Economic DevelopmentGenevaWorld Health Organization2001
  • who.int [homepage on the Internet]Cost-effectiveness thresholdsWorld Health Organization2005 [cited February 7, 2013]. Available from: http://www.who.int/choice/costs/CER_thresholds/en/index.htmlAccessed August 9, 2014
  • NeumannPJGreenbergDOlchanskiNVStonePWRosenABGrowth and quality of the cost-utility literature, 1976–2001Value Health2005813915841889
  • FangCOteroHJGreenbergDNeumannPJCost-utility analyses of diagnostic laboratory tests: a systematic reviewValue Health20111481010101822152169
  • Pharmaceutical Services DivisionPharmacoeconomic Guideline for MalaysiaPutrajayaMinistry of Health Malaysia2012
  • Food and Agriculture Organization Information DivisionApplications of Contingent Valuation Method in Developing Countries: A SurveyRomeFood and Agriculture Organization, United Nations2000
  • HoyosDMarielPContingent valuation: past, present and futurePrague Economic Papers20104329343
  • KingJTTsevatJLaveJRRobertsMSWillingness to pay for a quality-adjusted life year: implications for societal health care resource allocationMed Decis Making200525666767716282217
  • BobinacAVan ExelNJRuttenFFBrouwerWBWillingness to pay for a quality-adjusted life-year: the individual perspectiveValue Health20101381046105520825620
  • DonaldsonCBakerRBellSEuropean Value of a Quality Adjusted Life Year – Final Publishable ReportNewcastleNewcastle University2010 Available from: http://research.ncl.ac.uk/eurovaq/EuroVaQ_Final_Publishable_Report_and_Appendices.pdfAccessed November 18, 2012
  • Department of Statistics, MalaysiaPopulation distribution and basic demographic characteristics 2010PutrajayaDepartment of Statistics Malaysia2011 Available from: http://www.statistics.gov.my/portal/download_Population/files/census2010/Taburan_Penduduk_dan_Ciri-ciri_Asas_Demografi.pdfAccessed September 18, 2014
  • VanVoorhisCRWMorganBLUnderstanding power and rules of thumb for determining sample sizesTutor Quant Methods Psychol2007324350
  • EuroQol GroupEuroQol – a new facility for the measurement of health-related quality of lifeHealth Policy199016319920810109801
  • AhlertMBreyerFSchwettmannLWhat You Ask is What You Get: Willingness-to-Pay for a QALY in GermanyCESifo Working Paper No 4239MunichCESifo2013
  • HeckmanJJSample selection bias as a specification errorEconometrica1979471153161
  • Decision Support Unit, National Institute for Health and Clinical ExcellenceBriefing paper for the Methods Working Party on the Cost Effectiveness ThresholdLondonNational Institute for Health and Clinical Excellence2007
  • DolanPThe measurement of individual utility and social welfareJ Health Econ1998171395210176314
  • BergerMLBingeforsKHedblomECPashosCLTorranceGWDix SmithMHealth Care Cost, Quality, and OutcomesLawrenceville, NJInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR)2003
  • HaronSASharpeDLMasudJAbdel-GhanyMHealth divide: economic and demographic factors associated with self-reported health among older MalaysiansJ Fam Econ Iss2010313328337
  • Department of Statistics MalaysiaHousehold Income and Basic Amenities Survey ReportPutrajayaDepartment of Statistics, Malaysia2009
  • Costa-FontJRovira-FornsJWho is willing to pay for long-term care insurance in Catalonia?Health Policy2008861728417980931
  • SmithJPKingtonRSRace, socioeconomic status and health in late lifeMartinLGSoldoBJRacial and Ethnic Differences in Health of Older AmericansWashington, DCNational Academic Press1997106162
  • WeinsteinMCA QALY is a QALY is a QALY – or is it?J Health Econ1988728929010291478
  • ThavorncharoensapMTeerawattananonYNatanantSKulpengWYothasamutJWerayingyongPEstimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?Clinicoecon Outcomes Res20135293623345984
  • Department of Statistics, MalaysiaLabour force survey report, Malaysia 2011PutrajayaDepartment of Statistics Malaysia2012 Available from: http://www.statistics.gov.my/portal/download_Labour/files/labour_force/Laporan_Penyiasatan_Tenaga_Buruh_Malaysia2011.pdfAccessed September 18, 2014